Brief: Lee's Pharmaceutical Holdings Ltd Sees Net Profit Attributable Of Between Hk$25 Million And Hk$30 Million For Six Months
15/08/2022 12:30
Lee's Pharmaceutical Holdings Ltd 0950.HK :
* LEE'S PHARMACEUTICAL HOLDINGS LTD SEES NET PROFIT
ATTRIBUTABLE
OF BETWEEN HK$25 MILLION AND HK$30 MILLION FOR SIX MONTHS
* LEE'S PHARMACEUTICAL HOLDINGS LTD - EXPECTED RESULT DUE TO
HIGHER SELLING AND DISTRIBUTION EXPENSES INCURRED IN FIRST HALF
OF 2022, AMONG OTHERS
Source text for Eikon: ID:
Further company coverage: 0950.HK
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals